Jul 13, 2009
Female MS Volunteers Needed for Research Study
The University of California Los Angeles (UCLA) is looking for women with relapsing-remitting MS for a 24 -month study to see if there are less relapses with the treatment of Copaxone injections plus oral estriol as compared to the treatment of Copaxone injections plus oral placebo. We are looking for:
- Women 18-50 years old
- Diagnosed with definite RRMS
- Able to walk without any aids such as cane or walker
- Had at least one relapse within the last 2 years
You are not eligible for the study if you are pregnant, breast-feeding, smoke, or have other serious medical conditions. Those treated in the past with Copaxone, Avonex, Rebif or Betaseron will NOT BE EXCLUDED.
This study is being conducted by Barbara Giesser, M.D., Professor, UCLA, Department of Neurology. If you are interested, call Mike Montag, the study coordinator at (310)794-4020 or email MMontag@mednet.ucla.edu for further information.
This trial is funded by the National Multiple Sclerosis Society and the National Institutes of Health.
Learn more about gender differences in MS.
For more info about the trial visit: http://www.clinicaltrials.gov/ct2/show/NCT00451204?term=estriol+AND+multiple+sclerosis&rank=1.